Universal API Implementation Guide
1.1.20 - ci-build
Universal API Implementation Guide - Local Development build (v1.1.20) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
LinkID | Text | Definition | Answer |
---|---|---|---|
![]() ![]() | Questionnaire:https://dev.gene.com/fhir/uapi/fhirapi/Questionnaire/1234 | ||
![]() ![]() ![]() | Authorization # | #123456 | |
![]() ![]() ![]() | Onsite Pharmacy Name (Optional) | Name of pharmacy | |
![]() ![]() ![]() | Preferred Specialty Pharmacy (Optional) | SP ... | |
![]() ![]() ![]() | Do not contact patient | Yes | |
![]() ![]() ![]() | Ok to leave a detailed message? | No | |
![]() ![]() ![]() | Onsite Pharmacy? | Yes | |
![]() ![]() ![]() | Is prior authorization in place? | Yes | |
![]() ![]() ![]() | Is this a Prescription plan? | Yes | |
![]() ![]() ![]() | Re-verify benefits at PA expiration | Yes | |
![]() ![]() ![]() | Metastatic non-small cell lung cancer (NSCLC)? | Yes | |
![]() ![]() ![]() | Positive for neurotropic tropomyosoin receptor kinase (NTRK) fusions without a known acquired resistance? | Yes | |
![]() ![]() ![]() | Positive for ROS1? | Yes | |
![]() ![]() ![]() | Specialty Pharmacy? | Yes | |
![]() ![]() ![]() | TCPA Consent Provided? | Yes | |
![]() ![]() ![]() | Was the patient a clinical trial participant for this medicine? | Yes | |